Faculty profile

Weei-Yuarn Huang

Back to faculty

Associate ProfessorDepartment of Laboratory Medicine & PathobiologyUniversity of Toronto

Weei-Yuarn Huang

Associate Professor

Department of Laboratory Medicine & Pathobiology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
8 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

FGFR2 Fusions in Pancreatobiliary and Ampullary Cancers: High Detection Rate in FFPE Specimens of Intrahepatic Cholangiocarcinoma with Limited RNA Yields Using Amplicon-Based NGS Assay
Current Oncology · 2026 · senior author
Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.
Endocrine-related cancer · 2026
Evaluating HER2 Scoring Criteria in Endometrial Carcinoma: Gynecologic Versus Gastric Guidelines for Trastuzumab and Trastuzumab-Deruxtecan Selection.
Cancers · 2026

All 10 publications

Latest funding

Combining Advanced Metabolic MRI with Genomics to Refine the Treatment Paradigm for Grade 2/3 IDH-wildtype Astrocytoma ("Molecular Glioblastoma")
CIHR · 2024 · Co-investigator
$787,950
Delineating the role of cancer cell plasticity during the progression of pancreatic neuroendocrine tumours
CIHR · 2023 · Co-investigator
$1,093,950

All 2 grants and awards

10 publications.

FGFR2 Fusions in Pancreatobiliary and Ampullary Cancers: High Detection Rate in FFPE Specimens of Intrahepatic Cholangiocarcinoma with Limited RNA Yields Using Amplicon-Based NGS Assay

Simon Guertin, Niloofar Sina, Ken Kron, Kenneth J. Craddock, Amy McCarty, David M. Hwang, Weei-Yuarn Huang

Current Oncology2026Senior authorOpen Access

DOI: 10.3390/curroncol33090559

Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.

Kulathunga N, Chakraborty R, Li Y, Cherin E, Wang ZZ, Mar S, Khazaee T, Misura A, Lens-Pardo A, Ear PH, Schrader J, Garcia-Carbonero R, Chen L, Huang WY, Tsui H, Singh S, Law C, Hallet J, Demore CE, Leong HS, Michael IP

Endocrine-related cancer2026Open Access

DOI: 10.1530/erc-25-0377 PMID: 41744372

Evaluating HER2 Scoring Criteria in Endometrial Carcinoma: Gynecologic Versus Gastric Guidelines for Trastuzumab and Trastuzumab-Deruxtecan Selection.

Nofech-Mozes S, Olkhov-Mitsel E, Lu FI, Huang WY, Plotkin A

Cancers2026Open Access

DOI: 10.3390/cancers18122009 PMID: 42352541

Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer Center.

Plotkin A, Olkhov-Mitsel E, Huang WY, Nofech-Mozes S

Cancers202415 citationsOpen Access

DOI: 10.3390/cancers16112100 PMID: 38893219

Referred molecular testing as a barrier to optimal treatment decision making in metastatic non‐small cell lung cancer: Experience at a tertiary academic institution in Canada

Grace K. Grafham, Kenneth J. Craddock, Weei‐Yuarn Huang, Alexander V. Louie, Liying Zhang, David M. Hwang, Ambica Parmar

Cancer Medicine20249 citationsOpen Access

DOI: 10.1002/cam4.6886 PMID: 38317584

Analytical Validation and Performance Evaluation of Amplicon-Based Next-Generation Sequencing Assays for Detecting ERBB2 and Other Gene Amplifications in Solid Tumors.

Olkhov-Mitsel E, Chan D, Craddock KJ, Lin A, Luk G, Goswami RS, Wang H, Plotkin A, Nofech-Mozes S, Hwang DM, Huang WY

Cancers20242 citationsSenior authorOpen Access

DOI: 10.3390/cancers16233927 PMID: 39682116

PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology.

DeCoste R, Amemiya Y, Nersesian S, Westhaver L, Lee SN, Carter MD, Sapp HL, Stueck AE, Arnason T, Boudreau J, Seth A, Huang WY

Journal of clinical medicine20223 citationsSenior authorOpen Access

DOI: 10.3390/jcm11144241 PMID: 35888003

Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection.

Bormann Chung C, Lee J, Barritault M, Bringuier PP, Xu Z, Huang WY, Beharry A, Castillo J, Christiansen J, Lin JC, Sheffield BS

The Journal of molecular diagnostics : JMD2022

DOI: 10.1016/j.jmoldx.2021.09.008 PMID: 34656759

A growing vulvar mass in a post-menopausal woman

Youheng Xie, Danilo Giffoni M. M. Mata, Weei‐Yuarn Huang, Bojana Djordjevic, Katarzyna Joanna Jerzak

The Lancet Oncology20212 citations

DOI: 10.1016/s1470-2045(21)00521-0 PMID: 34735821

Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer.

Rasmussen SA, Arnason T, Huang WY

Journal of pathology and translational medicine2021Senior author

DOI: 10.4132/jptm.2020.12.22 PMID: 33472333

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Weei-Yuarn Huang

Research

Latest papers

Latest funding

FGFR2 Fusions in Pancreatobiliary and Ampullary Cancers: High Detection Rate in FFPE Specimens of Intrahepatic Cholangiocarcinoma with Limited RNA Yields Using Amplicon-Based NGS Assay

Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.

Evaluating HER2 Scoring Criteria in Endometrial Carcinoma: Gynecologic Versus Gastric Guidelines for Trastuzumab and Trastuzumab-Deruxtecan Selection.

Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer Center.

Referred molecular testing as a barrier to optimal treatment decision making in metastatic non‐small cell lung cancer: Experience at a tertiary academic institution in Canada

Analytical Validation and Performance Evaluation of Amplicon-Based Next-Generation Sequencing Assays for Detecting ERBB2 and Other Gene Amplifications in Solid Tumors.

PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology.

Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection.

A growing vulvar mass in a post-menopausal woman

Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer.

Combining Advanced Metabolic MRI with Genomics to Refine the Treatment Paradigm for Grade 2/3 IDH-wildtype Astrocytoma ("Molecular Glioblastoma")

Delineating the role of cancer cell plasticity during the progression of pancreatic neuroendocrine tumours

Frequent collaborators

Anna Plotkin

Sharon Nofech-Mozes

David Hwang

Fang-I Lu

Calvin Law

Julie Hallet

Simron Singh

Iacovos Michael

Arun Seth

Bojana Djordjevic

Lina Chen

Hubert Tsui

Jeanette Boudreau